Chen ZL, Fu H. Endoscopic retrograde cholangiopancreatography, endoscopic papillary balloon dilation, and laparoscopic hepatectomy for intra- and extrahepatic bile duct stones. World J Gastrointest Surg 2025; 17(1): 100544 [PMID: PMC11757201 DOI: 10.4240/wjgs.v17.i1.100544]
Corresponding Author of This Article
Hong Fu, Associate Chief Physician, Department of Hepatobiliary Surgery, Shaoxing People’s Hospital, No. 568 Zhongxing North Road, Yuecheng District, Shaoxing 312000, Zhejiang Province, China. zjufuhong@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Jan 27, 2025; 17(1): 100544 Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.100544
Endoscopic retrograde cholangiopancreatography, endoscopic papillary balloon dilation, and laparoscopic hepatectomy for intra- and extrahepatic bile duct stones
Zhi-Liang Chen, Hong Fu
Zhi-Liang Chen, Hong Fu, Department of Hepatobiliary Surgery, Shaoxing People’s Hospital, Shaoxing 312000, Zhejiang Province, China
Author contributions: Chen ZL designed the research and wrote the first manuscript; Chen ZL and Fu H contributed to conceiving the research and analyzing data; Chen ZL and Fu H conducted the analysis and provided guidance for the research; all authors reviewed and approved the final manuscript.
Institutional review board statement: This study was approved by the Ethic Committee of Shaoxing People’s Hospital.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: The authors state that they have no conflicts of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hong Fu, Associate Chief Physician, Department of Hepatobiliary Surgery, Shaoxing People’s Hospital, No. 568 Zhongxing North Road, Yuecheng District, Shaoxing 312000, Zhejiang Province, China. zjufuhong@163.com
Received: October 9, 2024 Revised: November 12, 2024 Accepted: November 29, 2024 Published online: January 27, 2025 Processing time: 79 Days and 5 Hours
Core Tip
Core Tip: Failure to receive timely and effective surgical intervention may cause massive invasion of the biliary tract by infectious substances in patients with both intra- and extrahepatic bile duct stones (BDSs), subsequently inducing obstructive suppurative cholangitis and liver abscesses, thereby posing a severe threat to life and health. This study analyzed the efficacy, surgical parameters, postoperative rehabilitation, hospital stay, medical expenses, and quality of life (QoL) of patients with intra- and extrahepatic BDSs treated with endoscopic retrograde cholangiopancreatography (ERCP) + endoscopic papillary balloon dilation (EPBD) + laparoscopic hepatectomy (LH). The ERCP + EPBD + LH approach has been confirmed to exhibit a remarkable therapeutic effect in patients with intra- and extrahepatic BDSs, facilitating postoperative recovery and improving the QoL, thereby meriting clinical application and popularization.
